×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
概要
This workshop will be conducted in Japanese Language only.
Online Registration has been closed. Onsite Registration will be available at Nihonbashi Life Science Building.
プログラム委員会
-
Asami Ezaki, MS Division of Strategic Planning and Evaluation & Office of Drug Discovery Support
Japan Agency for Medical Research and Development, Japan -
Yasuhiro Honsho Associate Director, Safety & Risk Management Department
Daiichi Sankyo Co., Ltd., Japan -
Yuji Ito Prescribing Information Group, RA Functions Dept., Regulatory Affairs Japan
Novartis Pharma K.K., Japan -
Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
Viatris Pharmaceuticals Japan Inc., Japan -
Ken Nakajima, RPh Quality Assurance Division Safety Management Department
Otsuka Pharmaceutical Factory, Inc, Japan -
Yuji Ohne Senior Director of Regulatory Compliance
Aurion Biotech Japan, Japan -
Keinosuke Okazaki Pharmacovigilance, Safety-1
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mikiko Shitara Senior Manager, Regulatory Affairs Dept.
Alexionpharma GK, Japan -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Akiyoshi Uchiyama President
Artage Inc., Japan
